Peter Wirth
Director at Zai Lab Ltd (ZLAB)
Peter Wirth has filed 18 insider reports with the SEC since January 2021, as director at Zai Lab Ltd (ZLAB), director at Syros Pharmaceuticals, Inc. (SYRS) and director at Forma Therapeutics Holdings, Inc. (FMTX). Peter Wirth made no open-market purchases or sales in the last 12 months. The latest filing, on June 22, 2026, reports grant or award at Zai Lab Ltd (ZLAB).
- Filings
- 18
- Companies
- 3
- Bought on market
- $571K
- Sold on market
- $278K
Companies where Peter Wirth is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 350,615 | $571K | $278K | $71.36 | $23.47-67% | Jun 22, 2026 | |
| Director | 16,000 | Mar 11, 2025 | |||||
| Director | 0 | Oct 14, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jun 17, 2026ZLABDirector Wirth Peter was granted 22,371 units of American Depositary Shares, increasing direct ownership by 6% to 416,121 unitsForm 4Grant or award
- Jun 18, 2025ZLABDirector Wirth Peter was granted 10,831 units of American Depositary Shares, increasing direct ownership by 3% to 393,750 unitsForm 4Grant or award
- Mar 11, 2025~$2,008SYRSPeter Wirth plans to sell 9,333 shares (~$2,008)Form 144Planned sale
- Jun 18, 2024ZLABDirector Wirth Peter was granted 21,253 units of American Depositary Shares, increasing direct ownership by 6% to 382,919 unitsForm 4Grant or award
- Jun 5, 2024SYRSWirth Peter was granted 4,000 shares, increasing direct ownership by 33% to 16,000 unitsForm 4Grant or award
- Jun 29, 2023ZLABSEC Form 4 filed by Wirth PeterForm 4Grant or award
- Jun 1, 2023SYRSSEC Form 4 filed by Wirth PeterForm 4Grant or award
- Dec 8, 2021+$285KZLABSEC Form 4: Wirth Peter bought $285,440 worth of American Depositary Shares (4,000 units at $71.36) (Amendment)Form 4Open-market purchase
- Dec 8, 2022-$278KZLABSEC Form 4: Wirth Peter sold $277,565 worth of American Depositary Shares (7,852 units at $35.35), decreasing direct ownership by 1% to 342,763 unitsForm 4Open-market sale
- Oct 14, 2022FMTXSEC Form 4: Wirth Peter closing all direct ownership in the companyForm 4Sale back to the companyTender of shares in a change of control
- Sep 16, 2022SYRSSEC Form 4: Wirth Peter was granted 8,000 sharesForm 4Grant or award
- Jun 8, 2022FMTXSEC Form 4: Wirth Peter was granted 4,500 shares, increasing direct ownership by 3% to 134,915 unitsForm 4Grant or award
- Jun 1, 2022SYRSSEC Form 4 filed by Wirth PeterForm 4Grant or award
- Jan 3, 2022ZLABSEC Form 4: Wirth Peter was granted 7,763 units of Ordinary Shares, increasing direct ownership by 2% to 350,615 unitsForm 4Grant or award
- Dec 8, 2021+$285KZLABSEC Form 4: Wirth Peter bought $285,440 worth of Ordinary Shares (4,000 units at $71.36), increasing direct ownership by 1% to 342,852 unitsForm 4Open-market purchase
- Jun 17, 2021FMTXSEC Form 4: WIRTH PETER was granted 2,750 units of Common Stock, increasing direct ownership by 2% to 130,415 unitsForm 4Grant or award
- Jun 8, 2021SYRSSEC Form 4 filed by WIRTH PETERForm 4Grant or award
- Jan 15, 2021ZLABSEC Form 4: Peter Wirth was granted 3,852 units of Ordinary Shares, increasing ownership by 1% to 338,852 unitsForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Peter Wirth.
Compare Peter Wirth with
- Peter Wirth vs Marsha Fanucci2 shared
- Peter Wirth vs Richard Gaynor1 shared
- Peter Wirth vs Yajing Chen1 shared
- Peter Wirth vs William Lis1 shared
- Peter Wirth vs Du Ying1 shared
- Peter Wirth vs Frazor Titus Edmondson III1 shared
Other insiders at the same companies
- Richard GaynorZLAB
- Yajing ChenZLAB
- William LisZLAB
- Du YingZLAB
- Frazor Titus Edmondson IIIZLAB
- John D DiekmanZLAB
- Scott W MorrisonZLAB
- Nisa LeungZLAB
- Michel VounatsosZLAB
- Leon O Moulder JrZLAB
- Yizhe WangZLAB
- Joshua L SmileyZLAB
- Rafael AmadoZLAB
- Kai-Xian ChenZLAB
- Srinivas AkkarajuSYRS
Questions about Peter Wirth
- What is Peter Wirth's role at Zai Lab Ltd?
- Peter Wirth reports to the SEC as director at Zai Lab Ltd (ZLAB), according to the latest filing on June 22, 2026. Peter Wirth has also filed as director at Syros Pharmaceuticals, Inc. (SYRS) and director at Forma Therapeutics Holdings, Inc. (FMTX).
- How many shares does Peter Wirth own?
- After the latest filing that states it, Peter Wirth directly owned 350,615 shares of Zai Lab Ltd (ZLAB) and 16,000 shares of Syros Pharmaceuticals, Inc. (SYRS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Peter Wirth bought or sold stock recently?
- The most recent open-market purchase was on December 8, 2021: bought 4,000 shares of Zai Lab Ltd (ZLAB) for $285K at an average of $71.36. The most recent open-market sale was on December 8, 2022: sold 7,852 shares of Zai Lab Ltd (ZLAB) for $278K at an average of $35.35.
- How do I get alerts when Peter Wirth files?
- Follow Peter Wirth on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Peter Wirth (SEC CIK 0001021041). Totals count each trade once, skipping amendments whose original is on file, from Jan 20, 2021 on. View on SEC EDGAR